tirzepatide vs vs. Semaglutide: What You Should Know GLP-1 Medications for Weight Loss:

The results showed that after 12 weeks, participants in the 50 mg and 100 mg groups lost an average of 10.4% and 13.1% of their body weight, respectively, compared to just 1.1% in the placebo group

The next decade may redefine obesity and metabolic disease management more dramatically than any era since the discovery of insulin.

Its broad melanocortin receptor profile means it should never be prescribed casually particularly given the skin and pigmentation considerations

We've had a lot of success stories in the veterinary world, David explains

Ye P, Li L, Richards RG, DiAugustine RP, DErcole AJ: Myelination is altered in insulin-like growth factor-I null mutant mice